REFERENCES
- Bassily, S., Farid, Z., Higashi, G. I., Kamel, I. A., El-Masry, N. A. & Watten, R. H. (1979). Chronic hepatitis B antigenemia in patients with hepatosplenic schistosomiasis. Journal of Tropical Medicine and Hygiene, 82, 248–251.
- Bassily, S., Farid, Z., Higashi, G. I. & Watten, R. H. (1978). Treatment of complicated schistosomiasis mansoni with oxamniquine. American Journal of Tropical Medicine and Hygiene, 27, 1284–1286.
- Bell, D. R. (1963). A new method for counting S. mansoni eggs in faeces with special reference to therapeutic trials. Bulletin of the World Health Organization, 41, 209–224.
- Da Silva, L. C., Sette, H. Jr., Christo, C. H., Saez-Alquezar, A., Carneiro, C. R. W., Lancet, C. M., Ohtsuki, N. & Rala, S. (1981). Praziquantel in the treatment of hepatosplenic form of schistosomiasis mansoni. Arzneim-Forsh/Drug Research, 31, 601–603.
- Dickmann, H. W. & Buhring, K. U. (1976). The fate of praziquantel in the organism: III. Metabolism in rat, beagle dog and rhesus monkey. European Journal of Drug Metabolism and Pharmcokinetics, 2, 107–112.
- Farid, Z., Higashi, G. I., Bassily, S., Trabolsi, B. & Watten, R. H. (1980). Treatment of advanced hepatosplenic schistosomiasis with oxamniquine. Transactions of the Royal Society of Tropical Medicine and Hygiene, 74, 400–401.
- Kilpatrick, M. E., El-Masry, N. A., Bassily, S. & Farid, Z. (1982). Oxamniquine versus imidazole for treatment of uncomplicated schistosomiasis mansoni infection. American Journal of Tropical Medicine and Hygiene, 31, 1164–1167.
- Obermeier, J. & Frohberg, H. (1977). Mutagenicity studies with praziquantel a new anthelmintic drug, tissue-, host- and urine-mediated mutagenicity assays. Archives of Toxicology, 38, 149–161.
- Teesdale, C. H. & Amin, M. A. (1976). Comparison of the Bell technique, a modified Kato thick smear technique and a digestion method for the field diagnosis of schistosomiasis mansoni. Journal of Helminthology, 50, 17–20.